Lv11
60 积分 2024-03-23 加入
Safety and pharmacokinetics of IBI112, an IL-23 monoclonal antibody, in Chinese healthy volunteers: a first-in-human phase 1 study
1个月前
已完结
An Oral Interleukin-23–Receptor Antagonist Peptide for Plaque Psoriasis
2个月前
已完结
Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder
4个月前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
5个月前
已完结
Naproxen concentrations in plasma and synovial fluid and effects on prostanoid concentrations
5个月前
已关闭
Pilot study of baricitinib for active Sjogren’s syndrome
6个月前
已完结
A profile of azetukalner for the treatment of epilepsy: from pharmacology to potential for therapy
6个月前
已完结
Translational Population‐Pharmacodynamic Modeling of a Novel Long‐Acting siRNA Therapy, Inclisiran, for the Treatment of Hypercholesterolemia
7个月前
已完结
Inclisiran siRNA Technology in the Management of Dyslipidemia: A Narrative Review of Clinical Trials
7个月前
已完结
Discovery and preclinical evaluations of JBD0131, a novel nitrodihydro-imidazooxazole anti-tuberculosis agent
7个月前
已完结
皖公网安备34019202002308
